<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/novartis-india-appoints-dr-chetan-p-head-medical-regulatory-pharmacovigilance</loc>
    <lastmod>2026-08-18T22:57:43+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Novartis India Appoints Dr. Chetan P. as Head of Medical, Regulatory and Pharmacovigilance</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6e4a583c-72d1-432f-a367-b2d0c3e71f2f/3f12f941-d7b8-4e42-bfec-c47170cef2b1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/hearzap-acquires-amplifon-india-hearing-healthcare-business</loc>
    <lastmod>2026-08-18T22:58:38+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Hearzap Acquires Amplifon India's Hearing Healthcare Business in Strategic Consolidation Move</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6e4a583c-72d1-432f-a367-b2d0c3e71f2f/c161a6bf-16af-4bc0-bae2-bd3dbc39e4cf.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/tianjin-kilo-pharmaceutical-fda-warning-letter-704a4-remote-review-2026</loc>
    <lastmod>2026-08-18T23:00:42+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Tianjin Kilo Pharmaceutical Receives FDA Warning Letter After Remote Records Review</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4da5c123-0ba9-408b-8622-f8a1a7ebd6aa/9a09ed14-c2ff-4398-a1f3-0d16242fa838.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/safrel-pharmaceuticals-fda-warning-letter-quality-unit-otc-2026</loc>
    <lastmod>2026-08-18T22:59:08+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Safrel Pharmaceuticals Receives FDA Warning Letter Citing Quality Unit Collapse Across OTC Drug Operations</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4da5c123-0ba9-408b-8622-f8a1a7ebd6aa/5e47c87a-77de-485b-9501-f7570b1b00bb.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/propanc-biopharma-phase-1b-feasibility-assessment-prp-solid-tumors</loc>
    <lastmod>2026-08-18T22:55:55+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Propanc Biopharma Initiates Feasibility Assessment for PRP in Advanced Solid Tumors</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4da5c123-0ba9-408b-8622-f8a1a7ebd6aa/b44ebc35-c891-4796-a965-aefabe70ab37.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fibrobiologics-chondrocyte-spheroids-cartilage-repair-preclinical-study</loc>
    <lastmod>2026-08-18T22:56:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>FibroBiologics Achieves Cartilage Repair in Preclinical Study Using Four-Day Chondrocyte Spheroid Process</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4da5c123-0ba9-408b-8622-f8a1a7ebd6aa/66db15a2-87ec-48fb-a6f2-b447d5558c38.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-public-comment-generative-ai-medical-device-regulation-2026</loc>
    <lastmod>2026-08-18T23:01:15+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>FDA Opens Public Comment on Generative AI Medical Device Regulation, Signaling Broader Framework Ahead</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4da5c123-0ba9-408b-8622-f8a1a7ebd6aa/6215ee40-1326-471c-a56c-d8f470e6b581.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/biocon-fda-approval-yesintek-ustekinumab-prefilled-autoinjector-us</loc>
    <lastmod>2026-08-18T23:03:47+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Biocon Gains FDA Approval for Yesintek Ustekinumab Prefilled Autoinjector in U.S. Market</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.biocon.com/wp-content/uploads/2020/07/downloadicon-01-50x50.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/coultreon-biopharma-appoints-prista-charuworn-cmo-sik3-inhibitor-phase-ii</loc>
    <lastmod>2026-08-18T15:11:40+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Coultreon Biopharma Appoints Prista Charuworn As CMO</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6e4a583c-72d1-432f-a367-b2d0c3e71f2f/e605464d-bba6-4e34-9653-b0ed4fdf20b1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/biocon-fda-approval-yesintek-prefilled-autoinjectors-us-biosimilar</loc>
    <lastmod>2026-08-18T13:23:58+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Biocon Wins FDA Nod for Yesintek Autoinjectors in US</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/BioconWinsFDANodforYesintekAutoinjectorsinUS20260818132354.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-cdc-vaers-reporting-obligations-vaccine-manufacturers-post-market-surveillance</loc>
    <lastmod>2026-08-18T13:25:28+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>FDA, CDC Reaffirm Vaccine Manufacturers’ VAERS Reporting Duties</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FDA,CDCReaffirmVaccineManufacturers’VAERSReportingDuties20260818132525.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-cdc-vaers-mandatory-reporting-obligations-vaccine-manufacturers-ncvia</loc>
    <lastmod>2026-08-18T13:23:38+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>FDA &amp; CDC Clarify VAERS Reporting Duties Under NCVIA</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/818f8418-3b0c-422a-9e15-74d580b91f2c/50f54ed8-f99d-4c8b-917b-6f6e8ef0b42f.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/emergent-bidefense-fda-approval-cyfendus-anthrax-vaccine-animal-rule</loc>
    <lastmod>2026-08-18T14:53:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>Emergent BioDefense Gains FDA Nod For CYFENDUS Anthrax Vaccine</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/EmergentBioDefenseGainsFDANodForCYFENDUSAnthraxVaccine20260818145323.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-hctp-electronic-registration-requirements-21-cfr-part-1271</loc>
    <lastmod>2026-08-18T14:51:41+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>FDA Reaffirms HCT/P E-Registration Rules for Tissue Establishments</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/PE-RegistrationRulesforTissueEstablishments20260818145135.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-cber-ends-notarization-becats-biologics-export-certification</loc>
    <lastmod>2026-08-18T13:24:28+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>FDA Ends Export Certificate Notarization, Moves Biologics To BECATS</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FDAEndsExportCertificateNotarization,MovesBiologicsToBECATS20260818132422.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cber-advances-global-biologics-strategy-ich-apec-harmonization</loc>
    <lastmod>2026-08-18T13:26:19+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00+05:30</news:publication_date>
      <news:title>CBER Advances Global Biologics Strategy Through ICH And APEC</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/CBERAdvancesGlobalBiologicsStrategyThroughICHAndAPEC20260818132609.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/optimus-pharma-dcgi-approval-tapinarof-cream-india</loc>
    <lastmod>2026-08-18T16:11:11+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Optimus Pharma Gains First-in-India DCGI Approval for Tapinarof Cream 1% in Dermatology</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/c3e97afd-8fd6-42cb-8fb4-19ba5eb3c446/e5702a9c-c1a5-4fd2-b883-36cee3a6ea86.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/artelo-biosciences-secures-us-patent-allowance-art27-13-commercial-formulation-2041</loc>
    <lastmod>2026-08-18T16:12:52+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Artelo Biosciences Secures U.S. Patent Allowance for ART27.13 Commercial Formulation Through 2041</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/c3e97afd-8fd6-42cb-8fb4-19ba5eb3c446/ee84849c-4c83-4dff-97ab-2fe1077ab052.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/lupin-gains-us-fda-approval-generic-pitolisant-tablets-bioequivalent-wakix</loc>
    <lastmod>2026-08-18T16:11:30+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Lupin Gains US FDA Approval for Generic Pitolisant Tablets Bioequivalent to Wakix</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/70281d53-88af-40b4-9910-0fc3490879a8/d5a0540e-31b4-42fb-8ca9-5888dd9830fd.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/johnson-johnson-secures-258b-option-acquire-sail-biomedicines-in-vivo-car-t</loc>
    <lastmod>2026-08-18T16:12:01+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Johnson &amp; Johnson Secures $2.58B Option to Acquire Sail Biomedicines for In Vivo CAR T Platform</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/70281d53-88af-40b4-9910-0fc3490879a8/f074c643-9994-4093-9baf-c6a140f1ce2f.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/telangana-merges-food-safety-drugs-control-tg-safe</loc>
    <lastmod>2026-08-17T18:50:10+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Telangana Merges Food Safety and Drugs Control Departments</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/TelanganaMergesFoodSafetyandDrugsControlDepartments(1)20260817185003.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sai-life-sciences-appoints-maneesh-pingle-president-discovery</loc>
    <lastmod>2026-08-17T18:58:49+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Sai Life Sciences Appoints Maneesh Pingle as President of Discovery Division</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/SaiLifeSciencesAppointsManeeshPingleasPresidentofDiscoveryDivision20260817185303.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/modi-global-top-five-indian-pharma-compliance-bar</loc>
    <lastmod>2026-08-17T18:51:11+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Modi Sets Global Top-Five Target for Indian Pharma, Raising the Compliance Bar</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ModiSetsGlobalTop-FiveTargetforIndianPharma,RaisingtheComplianceBar(1)20260817185043.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sun-pharma-us-court-ruling-lipitor-antitrust-litigation</loc>
    <lastmod>2026-08-17T18:49:34+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Sun Pharma Secures US Court Ruling Dismissing Lipitor Antitrust Litigation</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/SunPharmaSecuresUSCourtRulingDismissingLipitorAntitrustLitigation20260817184923.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/aurobindo-vai-classification-raleigh-facility-form-483</loc>
    <lastmod>2026-08-17T18:48:39+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Aurobindo Gains VAI Classification for Raleigh Facility After 11-Observation Form 483</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/AurobindoGainsVAIClassificationforRaleighFacilityAfter11-ObservationForm48320260817184832.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/tcs-launches-agentic-ai-platform-drug-development-pharmacovigilance</loc>
    <lastmod>2026-08-17T18:52:11+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>TCS Launches Agentic AI Platform Targeting Drug Development &amp; Pharmacovigilance Workflows</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/TCSLaunchesAgenticAIPlatformTargetingDrugDevelopment&amp;PharmacovigilanceWorkflows20260817185158.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cansinobio-nmpa-nda-acceptance-td5cp-adolescent-adult-pertussis-vaccine</loc>
    <lastmod>2026-08-17T14:45:57+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>CanSinoBIO Secures NMPA NDA Acceptance for Td5cp Adolescent &amp; Adult Pertussis Vaccine</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/CanSinoBIOSecuresNMPANDAAcceptanceforTd5cpAdolescentandAdultPertussisVaccine20260817120110.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/abbott-india-appoints-dr-sudarshan-jain-chairman</loc>
    <lastmod>2026-08-17T12:02:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:00+05:30</news:publication_date>
      <news:title>Abbott India Appoints Dr. Sudarshan Jain as Chairman</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FrAbbottIndiaAppointsDr.SudarshanJainasChairman20260817120209.png</image:loc>
    </image:image>
  </url>
</urlset>